NCT00137748View on ClinicalTrials.gov

Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2001

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions
Hypogammaglobulinemia
Interventions
DRUG

CMV-Ig

Drug: CMV-Ig

Trial Locations (1)

44195

Cleveland Clinic Foundation, Cleveland

All Listed Sponsors
lead

The Cleveland Clinic

OTHER

NCT00137748 - Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients | Biotech Hunter | Biotech Hunter